Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
~$44B
P/E ratio
~25×
Div yield
~2.7%
Revenue (FY25)
$21.8B
Rev. growth (FY25)
+8%
Dividend streak
53 yrs
Post-spin focus
Pure-play MedTech
Profit margin
~13%
In plain English
Becton Dickinson is one of the world's biggest makers of the everyday tools of medicine — the needles, syringes, IV catheters and lab specimen tubes used billions of times a year in hospitals — plus surgical and vascular devices (from the C.R. Bard takeover) and patient monitors (from Edwards' Critical Care unit). In February 2026 it spun off its Biosciences & Diagnostics arm into Waters, becoming a focused 'pure-play MedTech' company.
In simple terms
What Becton Dickinson really sells
Becton Dickinson is one of the world's biggest makers of the everyday tools of medicine — the needles, syringes, IV catheters and lab specimen tubes used billions of times a year in hospitals — plus surgical and vascular devices (from the C.R. Bard takeover) and patient monitors (from Edwards' Critical Care unit). In February 2026 it spun off its Biosciences & Diagnostics arm into Waters, becoming a focused 'pure-play MedTech' company.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.